Oxalis Group Limited has been acquired by Eaton Corporation
The private shareholders of Oxalis Group Limited have sold the company to Eaton Corporation for an undisclosed consideration.
Oxalis Group is engaged in the design, certification, manufacture and distribution of telecommunication products and solutions for use in extreme oil, gas and marine related environments. Solutions include closed-circuit TV camera stations, public address/general alarm systems and other electrical products that protect and safeguard assets, infrastructure and people.
Eaton provides energy-efficient solutions that help customers to effectively manage electrical, hydraulic and mechanical power more efficiently, safely and sustainably.
Oaklins Cavendish, based in the UK, advised the shareholders of Oxalis Group on the sale of the business to Eaton Corporation.
Talk to the deal team
Lord Leigh of Hurley
Oaklins Cavendish
Related deals
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Learn moreFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
Learn moreBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn more